Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong
· Delayed Price · Currency is HKD 8.13
+0.12 (1.50%)
At close: Mar 10, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.93 billion as of March 10, 2026. Its market cap has increased by 26.13% in one year.
Market Cap
1.93B
Enterprise Value
1.50B
Revenue
1.43B
Ranking
n/a
PE Ratio
13.44
Stock Price
8.13
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has increased from 1.88B to 1.93B, an increase of 3.05%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.93B | 4.28% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Zhaoke Ophthalmology | 1.85B |
| Frontage Holdings | 2.23B |
| Cutia Therapeutics | 1.71B |
| Mabpharm | 1.69B |
| Clover Biopharmaceuticals | 2.51B |
| Jiangsu Recbio Technology | 2.65B |
| Antengene Corporation | 2.66B |